Vaginal Infections During Pregnancy: Why Treatment Is Chosen Carefully and Follow-Up Matters

It usually starts with a small uncertainty. Someone twenty-two weeks along notices that her discharge looks different, or itches in a way it didn’t last month, and she does what most people do at eleven at night: she searches. Within minutes she has read that this is completely normal and also that it could harm the baby. Both statements are sitting on the same screen, and neither one tells her what to do before breakfast.

That gap between reassurance and alarm is exactly where a vaginal infection during pregnancy lives. Hormones change the vagina’s chemistry, so more discharge is expected. Yet those same changes make yeast overgrowth more likely, and a few infections genuinely deserve prompt attention.

The thoughtful path is neither panic nor shrugging it off. It is understanding why clinicians test before they treat, why some medicines are favored over others in pregnancy, and why a follow-up visit is often part of the plan rather than an afterthought.

What counts as a vaginal infection during pregnancy?

The phrase covers several different conditions that happen to share a location. The vagina normally hosts a community of microbes dominated by lactobacilli, bacteria that produce lactic acid and keep the environment mildly acidic. When that balance shifts, or when an organism arrives that does not belong, the result is what clinicians call vaginitis: inflammation of the vagina, often with changed discharge, itching, or odor (MedlinePlus).

Three infections account for most cases in pregnancy. Vulvovaginal candidiasis, usually called a yeast infection, is an overgrowth of a fungus that already lives quietly in many people. Bacterial vaginosis, or BV, is not one invading germ but a shift in which bacteria dominate. Trichomoniasis is caused by a single-celled parasite passed between sexual partners.

A fourth organism belongs in this conversation even though it rarely causes symptoms. Group B streptococcus, a bacterium many healthy adults carry in the gut and vagina, matters in pregnancy because it can pass to the baby during birth (CDC).

Why does the distinction matter so much? Because a vaginal infection during pregnancy is not treated as a single thing. A yeast infection responds to antifungal medicines; BV and trichomoniasis respond to antibiotics of a particular class; group B strep is handled during labor rather than in the clinic weeks earlier. Treating the wrong one does nothing useful and delays the right approach.

Pregnancy also raises the stakes for accuracy. Clinicians weigh each medicine against what is known about its use while a baby is developing, and they often prefer options that stay local rather than circulating through the whole body. That is the first reason treatment is chosen carefully, and it explains why the story begins with testing rather than a tube of cream.

What is the most common infection in pregnancy?

Among vaginal conditions, bacterial vaginosis takes the top spot. CDC describes BV as the most common vaginal condition in women of reproductive age, and NHS calls it the most common cause of unusual discharge. Yeast infections come a close second: Mayo Clinic notes that as many as three out of four women will have at least one yeast infection during their lifetime, and pregnancy is one of the periods when risk climbs.

People are often surprised that BV outranks yeast, partly because yeast has a memorable set of symptoms and BV frequently has none. Roughly half of people with BV notice nothing at all, which is why it often turns up on tests performed for another reason (CDC).

Step back from the vagina, though, and the answer changes. Urinary tract infections are also frequent in pregnancy because the growing uterus slows urine flow and hormones relax the tubes that drain the kidneys. Group B strep carriage is so widespread that CDC estimates about one in four pregnant women carry the bacterium at any given time. Carriage is not infection, but it shapes care at delivery.

The point of ranking these is not to create a leaderboard of worry. It is to reset expectations. Someone who feels different “down there” during pregnancy is far more likely to have a benign shift in discharge, a yeast overgrowth, or BV than anything rare. That is reassuring. It is also a reason not to self-treat, because the two most common conditions call for entirely different medicines, and their symptoms can look alike to the untrained eye.

Why pregnancy changes the vagina and invites imbalance

Estrogen is the main character here. During pregnancy it rises steadily, and one of its effects is to thicken the vaginal lining and load its cells with glycogen, a storage form of sugar. Lactobacilli feast on that glycogen and produce lactic acid, which is why the vagina stays acidic. So far, so protective.

The same sugar also feeds yeast. Candida thrives in a warm, moist, glycogen-rich environment, which is a fair description of the pregnant vagina. Mayo Clinic lists pregnancy alongside uncontrolled diabetes and recent antibiotic use as conditions that raise yeast infection risk, and the common thread is either more available sugar or fewer competing bacteria.

Immune tone shifts as well. Pregnancy does not switch the immune system off, but it recalibrates certain responses so the body tolerates a fetus that is genetically half foreign. Some of those adjustments make it slightly harder to keep fungal overgrowth in check.

Then there is the mechanical reality. More discharge is normal in pregnancy; NHS describes increased, thin, clear or milky discharge as expected. The extra moisture, plus tighter clothing and less airflow, creates conditions yeast enjoys. Meanwhile any disruption to lactobacilli, whether from antibiotics for another problem or from douching, can tip the balance toward the mixed anaerobic bacteria that define BV.

Why does this mechanism matter for treatment? Because it explains recurrence. A person can be treated appropriately, feel better, and still see the problem return while the hormonal conditions that favored it remain in place. That is not treatment failure or anything the patient did wrong. It is biology, and it is a central reason follow-up conversations are built into good pregnancy care rather than left to chance.

Can I get a yeast infection while pregnant, and does it harm the baby?

Yes, and it is one of the most frequent reasons pregnant patients raise a concern at a routine visit. Vulvovaginal candidiasis is an overgrowth of Candida, most often a species called Candida albicans, which many people carry harmlessly. Pregnancy shifts the odds toward overgrowth for the hormonal reasons described above.

The reassuring part comes first. A yeast infection in the vagina is not known to cause miscarriage, birth defects, or preterm labor. It is uncomfortable rather than dangerous to the pregnancy itself, which is why clinicians treat it primarily to relieve symptoms.

Two practical wrinkles deserve honesty. First, a baby born through a vagina with active yeast can pick up the fungus during delivery, which sometimes shows up afterward as oral thrush in the newborn or a yeast-related diaper rash. These are common, treatable pediatric issues rather than emergencies, but they are one reason care teams like to have symptomatic yeast under control as the due date approaches. Second, treating yeast in pregnancy tends to take longer than outside pregnancy. CDC guidance favors longer topical antifungal courses for pregnant patients rather than the very short products many people are used to, because the environment that encouraged the overgrowth is still present.

A word about what the symptoms cannot tell you. Itching, thick white discharge and soreness are classic for yeast, yet studies of self-diagnosis consistently show that people who are confident they have yeast are wrong a substantial share of the time, and BV or trichomoniasis is sitting underneath. In pregnancy, where the wrong medicine wastes time and the right diagnosis affects delivery planning, a quick swab is worth more than a guess.

Bacterial vaginosis in pregnancy: what the evidence actually shows

BV is where the internet tends to frighten people, so precision helps. Bacterial vaginosis is a shift in the vaginal ecosystem: protective lactobacilli fall, and a mixed population of bacteria that prefer low-oxygen conditions rises. It is not classified as a sexually transmitted infection, though it is more common in sexually active people and after a new partner (NHS).

Observational research has linked BV during pregnancy with higher rates of preterm birth, premature rupture of the membranes, and low birth weight, and CDC notes these associations. Association is not the same as cause, and here is the honest complication: trials that screened pregnant women without symptoms, found BV, and treated it did not reliably reduce preterm births in the general population. For that reason CDC does not recommend routine screening of all pregnant patients for BV, and treatment is recommended when symptoms are present.

So what does that mean for the person reading this with a fishy odor and thin grey discharge? Symptomatic BV in pregnancy is treated. The medicines used are antibiotics from classes that have long track records in pregnancy, and CDC lists both oral and vaginal options as acceptable; the prescribing clinician decides which fits the situation. Treatment relieves symptoms and clears the bacterial imbalance, and the guidelines are explicit that the benefit for the pregnancy itself is less certain than people assume.

Recurrence is common after BV treatment, in pregnancy and outside it (CDC). That single fact drives much of the follow-up advice. Some guidance has suggested a repeat evaluation after treatment during pregnancy, particularly when symptoms linger or a patient has a history of preterm birth. Whether that applies to a given person is a decision for the treating team, informed by history and by how the symptoms respond.

Trichomoniasis and group B strep: the infections people forget

Trichomoniasis gets far less attention than yeast or BV, yet it carries more weight in pregnancy. It is caused by Trichomonas vaginalis, a single-celled parasite passed through sexual contact. Many carriers have no symptoms; others notice frothy, discolored discharge, irritation or discomfort when urinating. CDC associates trichomoniasis in pregnancy with preterm delivery, premature rupture of membranes and low birth weight, and recommends treatment for pregnant patients who test positive.

Two features make follow-up especially important here. Because it is sexually transmitted, partners are treated as well, otherwise reinfection is likely. And because reinfection rates are high, CDC recommends retesting within three months after treatment, regardless of whether a partner was treated. That retest is not a sign of distrust. It reflects how often this particular organism comes back.

Group B streptococcus is a different story altogether. It is a bacterium, not an infection in the usual sense, and most people who carry it feel entirely well. Its significance is that during labor it can reach the baby, where in a small number of cases it causes serious illness in the first days of life (CDC). For that reason, care in many health systems includes a swab late in pregnancy, typically between 36 and 37 weeks according to CDC, to check for carriage.

Here is the part that surprises people: a positive GBS swab is not treated with a course of antibiotics during pregnancy. Clearing it early does not work, because the bacterium tends to return before delivery. The plan instead is antibiotics given through a vein during labor, which lowers the chance of transmission at the moment it matters. Knowing that in advance helps a positive result feel like a plan rather than a problem.

How do I know if I have an infection while pregnant?

The honest answer is that you often cannot tell on your own, and the reason is not a lack of attentiveness. Pregnancy itself produces more discharge, occasional mild irritation, and a heightened awareness of every sensation. Layer a real infection on top and the signals blur.

What clinicians look for is change rather than any single feature. Discharge that shifts noticeably in color, texture or smell; itching or burning that persists rather than passing; soreness during sex or urination; a new unpleasant odor, particularly after sex. NHS offers a useful anchor: discharge that is thin, clear or white and does not smell unpleasant is usually the normal increase of pregnancy, whereas a strong or fishy smell, a greenish or yellow tint, or accompanying itch and pain warrant a conversation.

None of that is a diagnosis. Yeast and BV can both cause itching. BV and trichomoniasis can both cause odor. Urinary symptoms can come from a bladder infection or from vaginal irritation. This overlap is precisely why guidelines steer pregnant patients toward assessment rather than self-treatment.

There is a second reason to check rather than guess. A few conditions that matter to the pregnancy are silent. BV frequently has no symptoms. Trichomoniasis often has none. Group B strep almost never does. Prenatal care includes testing for several of these because waiting for a symptom would mean waiting for something that may never appear.

The takeaway is not that every sensation demands a visit. It is that a persistent, noticeable change is worth a swab, and that a vaginal infection during pregnancy is easier to sort out with a five-minute examination than with a week of worrying and an unproven remedy.

What actually happens when a vaginal infection is diagnosed in pregnancy

The visit is shorter and less dramatic than most people expect. A clinician will ask about the discharge, its smell and timing, any itching or pain, recent antibiotics, sexual partners and previous infections. Those questions do more than fill a form; they steer which tests are ordered.

The examination usually involves a speculum, the same instrument used for a cervical screening test, so the clinician can look at the vaginal walls and cervix and collect a sample of discharge with a soft swab. That takes moments. Pregnant patients often ask whether this is safe, and it is; the cervix is not entered, and the procedure does not disturb the pregnancy.

Several things can happen to the sample. A pH test uses a paper strip: a normally acidic vagina reads low, while BV and trichomoniasis typically push the reading higher. Under a microscope, a clinician may see budding yeast, the clue-cell pattern typical of BV, or the moving parasites of trichomoniasis. Many clinics now send swabs for molecular testing, which detects the genetic material of specific organisms and returns results within days rather than minutes.

Group B strep testing is separate and scheduled, with a swab of the lower vagina and rectum late in the third trimester (CDC). If a urinary infection is suspected, a urine sample is cultured.

Why so much effort for a discharge complaint? Because the treatments diverge. Antifungals do nothing for BV. The antibiotics used for BV do nothing for yeast and may even encourage it. Trichomoniasis requires partner treatment and a follow-up test. A confirmed diagnosis lets the care team pick the medicine with the best pregnancy track record for that specific organism, rather than covering every possibility at once.

Why treatment is chosen carefully: how the medicines work

Two questions drive every prescribing decision here. Does the medicine reach the problem, and how much of it reaches the rest of the body? In pregnancy, the second question carries extra weight.

Antifungals used for yeast infections mostly belong to a class called azoles. They interfere with the fungus’s ability to build its cell membrane, so the yeast cannot maintain itself and dies back. Azoles come as creams, vaginal inserts and tablets swallowed by mouth. The topical forms act where they are placed and very little enters the bloodstream. Oral azoles circulate throughout the body. CDC recommends topical azoles rather than oral antifungals for treating yeast during pregnancy, because the systemic exposure from oral forms is harder to justify when a local option works.

BV and trichomoniasis are treated with antibiotics that target low-oxygen bacteria and certain parasites by damaging their DNA. The generic names in this group, metronidazole and clindamycin, appear in CDC guidance as acceptable in pregnancy, in oral or vaginal forms depending on the diagnosis. Trichomoniasis specifically requires an oral medicine, because the parasite can lodge in places a cream will not reach. The choice between forms, and the length of a course, sits with the prescribing clinician.

Timing also shapes decisions. Clinicians weigh which trimester a patient is in, whether symptoms are severe enough to justify treatment now versus watchful waiting, and whether a different medicine taken for something else might interact.

None of this means pregnant patients are left untreated. It means the menu is narrower and the reasoning is deliberate. When someone wonders why a clinician prescribed a week-long cream instead of the quick fix a friend used, this is the answer: the aim is to treat effectively while keeping the baby’s exposure as low as the evidence allows.

Are over-the-counter antifungal creams safe during pregnancy?

This is among the most searched questions on the topic, often phrased around a specific product name. The product itself matters less than two features: what class of medicine it contains, and how long the course runs.

Most pharmacy shelf antifungals for vaginal use are topical azoles, the class CDC and Mayo Clinic identify as the preferred option for yeast infections in pregnancy. Applied as a cream or vaginal insert, they act locally, and absorption into the bloodstream is minimal. From the standpoint of the medicine itself, these are the very same active ingredients a clinician would choose.

So why do guidelines and clinicians still say “talk to us first”? Three reasons, none of them about the cream being dangerous.

First, the diagnosis may be wrong. Self-diagnosed yeast is frequently BV or something else, and an antifungal will not help those. In pregnancy the delay matters more.

Second, the packaging may push toward the shortest course. CDC guidance for pregnant patients favors longer topical courses over the very short regimens, because the conditions feeding the yeast persist. A product chosen for convenience may undertreat.

Third, oral antifungal tablets are a different matter. Some are available without prescription in certain places, and clinicians generally avoid them in pregnancy, particularly in the first trimester, because of questions raised in observational studies about systemic exposure. This is exactly the sort of nuance a label cannot convey.

The practical middle ground many clinicians take: if you have had a confirmed yeast infection before, recognize the pattern, and are already in prenatal care, call the office. A brief conversation can confirm that a topical azole is reasonable, suggest the form and course length appropriate to pregnancy, and set a point at which to check back if symptoms do not settle. That is not gatekeeping; it is the follow-up half of careful treatment.

Who is usually treated right away, and who is usually asked to wait

Not every positive test leads to a prescription, and understanding the logic prevents a great deal of confusion.

Symptomatic infections are treated. A pregnant patient with itching and discharge from confirmed yeast, with odor and discharge from BV, or with any evidence of trichomoniasis, will typically be offered treatment promptly (CDC). Relief of symptoms is reason enough, and for trichomoniasis the potential pregnancy outcomes add urgency.

Asymptomatic BV is the grey zone. Because trials of screening and treating symptom-free BV in low-risk pregnancies did not consistently reduce preterm birth, CDC does not recommend routine screening, and a clinician who finds BV incidentally in a patient without symptoms may reasonably discuss watchful monitoring. Some care teams take a different view for patients with a prior preterm birth, where the calculus shifts. This is a judgment call, and it belongs to the team who knows the full history.

Group B strep carriers are asked to wait by design. Treatment during pregnancy does not keep the bacterium away, so the plan is antibiotics during labor rather than a course in the clinic weeks earlier (CDC). A positive swab is filed in the birth plan, not treated on the spot.

Timing within pregnancy also influences decisions. Clinicians sometimes prefer to defer a non-urgent treatment past the first trimester when the medicine in question has less reassuring early-pregnancy data, provided symptoms are tolerable. Conversely, an infection identified close to the due date may be treated promptly so the birth canal is as settled as possible.

Patients who benefit from a lower threshold to treat include those with diabetes, with recurrent infections, or with immune conditions. What unites all of these groups is that the decision rests on the individual picture rather than on the test result alone, which is why a positive result should prompt a conversation rather than an assumption.

The main vaginal infections in pregnancy compared

Holding these conditions side by side makes the reasoning behind different plans easier to see. The table below summarizes what mainstream guidance says about each; it is a map, not a self-diagnosis tool.

Condition	What it is	Typical clues	Usual approach in pregnancy	Follow-up emphasis
Yeast infection (vulvovaginal candidiasis)	Overgrowth of Candida fungus	Itching, thick white discharge, soreness	Topical azole antifungal; longer courses favored (CDC)	Recheck if symptoms persist; newborn thrush possible if active at birth
Bacterial vaginosis	Shift toward mixed low-oxygen bacteria	Thin grey discharge, fishy odor; often silent	Antibiotic if symptomatic; routine screening not recommended (CDC)	Recurrence common; repeat evaluation sometimes considered
Trichomoniasis	Sexually transmitted parasite	Frothy discolored discharge, irritation; often silent	Oral antibiotic; partners treated (CDC)	Retest within three months (CDC)
Group B strep carriage	Common bacterium carried without illness	None	Swab at 36-37 weeks; antibiotics during labor if positive (CDC)	Result recorded in birth plan

A few patterns stand out. Two of the four conditions are frequently silent, which is why prenatal testing does not wait for complaints. Two require oral medicines because a cream cannot reach where the organism lives. Only one, trichomoniasis, involves partner treatment, and it is also the one with a scheduled retest.

Notice too that the column labeled follow-up is never empty. Whether it is a retest, a recheck if symptoms linger, or a note in the delivery record, each condition carries some form of continuation. Careful treatment in pregnancy is less a single prescription than a short arc: identify, treat appropriately, and confirm the plan held.

What the following days and weeks usually look like, and why follow-up matters

Most people want to know when they will feel better, and the honest answer is that it depends on the organism and the form of treatment.

With topical antifungals for yeast, itching and irritation often begin easing within the first few days, though the full course should be completed as directed because stopping early invites relapse. Mild burning when a cream is applied is common and usually settles. With antibiotics for BV, odor and discharge typically improve over the course of treatment; with trichomoniasis, symptoms generally resolve as the parasite clears, and partners are expected to complete their own treatment before resuming sex.

Here is what people are rarely told: feeling better is not the end of the story in pregnancy, for three reasons.

Yeast can follow antibiotics. Treating BV disrupts bacteria, and that occasionally opens the door to Candida overgrowth a week or two later. Recognizing this sequence stops it from feeling like a mystery.

BV comes back. CDC describes recurrence as common. A repeat of symptoms weeks after treatment does not mean the first course failed; it may mean the hormonal environment favored a return, and the care team will decide whether to treat again or adjust the approach.

Trichomoniasis warrants a retest. CDC recommends checking again within three months because reinfection is frequent. That appointment is part of the treatment, not an optional extra.

For group B strep, the weeks after a positive swab are about planning rather than treatment: making sure the result is in the delivery record and that the birthing team knows antibiotics during labor are intended.

The thread connecting all of these is the same. A vaginal infection during pregnancy sits inside a body whose chemistry is actively changing, so the sensible expectation is treat, watch, and check. Anyone whose symptoms have not clearly improved by the end of a prescribed course, or that return, should let the team know rather than assume it is simply pregnancy.

What people often get wrong about vaginal infections in pregnancy

Myths cluster around this topic, partly because it is private and partly because the internet rewards alarm. A few corrections, each grounded in mainstream guidance.

“A yeast infection will hurt the baby.” Vaginal yeast is not linked to miscarriage or birth defects. The realistic consequence is discomfort, plus a chance of newborn thrush if it is active at delivery, both of which are treatable.

“Every pregnant woman should be screened for BV to prevent preterm birth.” That sounds logical, and researchers hoped it would be true. Trials in low-risk pregnancies did not show a clear reduction in preterm birth from screening and treating silent BV, which is why CDC does not recommend routine screening.

“Antibiotics are always off limits in pregnancy.” Some are avoided, but the antibiotics used for BV and trichomoniasis have long track records and appear in CDC guidance for pregnant patients. Refusing treatment for a confirmed infection out of blanket fear can do more harm than the medicine.

“Yogurt, garlic or tea tree oil will clear it.” There is no reliable evidence that any of these treats a vaginal infection, and inserting anything unstudied into the vagina during pregnancy adds risk without demonstrated benefit. Probiotic research is ongoing and unsettled; it has not replaced standard treatment in any guideline.

“Douching keeps the vagina clean.” Douching washes out protective lactobacilli and is associated with a higher likelihood of BV (NHS). The vagina cleans itself; washing the outside with water is enough.

“A positive group B strep test means I have an infection.” It means carriage, which is common and harmless to the carrier. The plan is antibiotics in labor, not treatment now.

“If it comes back, the treatment did not work.” Recurrence, especially of BV and yeast, reflects the hormonal environment of pregnancy more than any failure. It is a reason for follow-up, not self-blame.

Questions to ask your care team

A short list carried into an appointment turns a rushed encounter into a useful one. These questions map onto the decisions clinicians are actually making, so the answers tend to be concrete.

• Which infection do I have, and how was it confirmed? Knowing whether the diagnosis rests on a swab, a microscope or a molecular test clarifies how certain it is.
• Is treatment recommended now, or is watching reasonable at this stage of my pregnancy? This surfaces the symptomatic-versus-silent distinction directly.
• Why this form of medicine, cream or tablet, for my situation? The answer will usually involve where the organism lives and how much medicine reaches the bloodstream.
• What should I expect to feel over the next week, and what would tell me the treatment is not working?
• Does my partner need testing or treatment? Essential for trichomoniasis, not usually for yeast or BV.
• Will I need a repeat test or a follow-up visit, and when? This is the question most often left unasked.
• Could this treatment lead to another problem, such as yeast after antibiotics, and what should I do if so?
• How does this affect my delivery plan? Particularly relevant for group B strep and for yeast that is active close to the due date.
• Is there anything in my history, such as diabetes or a prior preterm birth, that changes how you would approach this?
• If symptoms return after treatment, should I call, or come in?

One more, worth asking even when everything is straightforward: what is the normal range of discharge for me at this stage, so I know what counts as a change? That baseline makes every later judgment easier, and it turns the patient into a well-informed partner in her own follow-up rather than a bystander waiting for the next appointment.

When to call your doctor

Most vaginal infections in pregnancy are uncomfortable rather than urgent, and a routine call to the prenatal office is the right first step for a persistent change in discharge, itching, odor or soreness. A few situations move faster.

Contact your care team the same day if you notice any of the following:

• Vaginal bleeding, beyond light spotting after an examination.
• A sudden gush or steady trickle of watery fluid, which could signal that the membranes have ruptured.
• Regular tightening or cramping of the uterus before 37 weeks, or lower back pain that comes and goes in a pattern.
• Fever, chills, or feeling generally unwell alongside pelvic symptoms.
• Pain in the lower abdomen or pelvis that is severe, constant or worsening.
• Burning with urination together with pain in the flank or lower back, or blood in the urine, which may indicate a kidney infection.
• Discharge that is green, yellow, frothy or foul-smelling and appeared quickly.
• Symptoms that have not clearly improved by the end of a prescribed course, or that return within a few weeks of treatment.
• A noticeable decrease in the baby’s usual movements, at any point in the third trimester.

Seek emergency care immediately for heavy bleeding, severe abdominal pain, high fever with confusion or rapid breathing, or any symptom that feels frightening in its intensity. Trust that instinct; it is rarely wrong in pregnancy.

These lists exist to help you decide when to pick up the phone, not to diagnose anything. Every decision about testing, treatment, timing and follow-up belongs with the team looking after your pregnancy, who can weigh your history, your stage of gestation and your examination together. If you are unsure whether something warrants a call, that uncertainty itself is a good enough reason to make it.

Frequently asked questions

Is it safe to use an over-the-counter antifungal cream during pregnancy?

Topical azole antifungal creams and inserts are the class of medicine CDC and Mayo Clinic identify as preferred for yeast infections in pregnancy, because very little is absorbed into the bloodstream. Clinicians still ask you to check in first, since self-diagnosed yeast is often BV or something else, and pregnancy typically calls for a longer course than the shortest shelf products. Oral antifungal tablets are generally avoided in pregnancy.

Can I get a yeast infection while pregnant?

Yes, and it is one of the most common reasons pregnant patients raise a concern. Higher estrogen increases glycogen in vaginal cells, which feeds Candida, and immune adjustments in pregnancy make overgrowth easier. Vaginal yeast is not linked to miscarriage or birth defects; the main consequences are discomfort and a chance of newborn thrush if it is active at delivery. Treatment in pregnancy is usually topical and tends to take longer.

What is the most common infection in pregnancy?

Among vaginal conditions, bacterial vaginosis is the most common, with yeast infections close behind. BV frequently causes no symptoms, so it is often found on testing rather than reported. Beyond the vagina, urinary tract infections are also frequent during pregnancy, and about one in four pregnant women carry group B strep, which is carriage rather than infection but shapes delivery care.

How do I know if I have an infection while pregnant?

Often you cannot be certain without a test, because pregnancy itself increases discharge and sensitivity. Clinicians focus on change: discharge that becomes noticeably grey, green, yellow or frothy, a strong or fishy odor, or itching, burning and soreness that persist. Several relevant conditions, including BV and trichomoniasis, are frequently silent, which is why prenatal care includes testing rather than waiting for symptoms.

Does bacterial vaginosis in pregnancy cause preterm birth?

BV is associated with preterm birth in observational studies, but trials that screened and treated symptom-free pregnant women did not consistently reduce preterm deliveries. For that reason CDC does not recommend routine BV screening in pregnancy, while symptomatic BV is treated. Whether to treat BV found without symptoms is a judgment for the care team, particularly for patients with a prior preterm birth.

Which antibiotics are used for a vaginal infection during pregnancy?

BV and trichomoniasis are treated with antibiotics that target low-oxygen bacteria and certain parasites; CDC guidance lists metronidazole and clindamycin, in oral or vaginal forms depending on the diagnosis, as acceptable in pregnancy. Trichomoniasis requires an oral medicine because the parasite reaches places a cream cannot. The choice of medicine, form and length of course rests with the prescribing clinician.

Why did my yeast infection come back after treatment while pregnant?

Recurrence in pregnancy usually reflects the hormonal environment rather than treatment failure. Estrogen keeps vaginal glycogen high, so Candida has a steady food supply, and antibiotics taken for another problem can reduce protective bacteria. Yeast sometimes follows BV treatment for the same reason. A return of symptoms is a reason to contact your care team, who may re-examine you and adjust the plan.

What happens if a vaginal infection is untreated during pregnancy?

It depends on the organism. Untreated yeast mainly causes ongoing discomfort and a chance of newborn thrush. Untreated symptomatic BV keeps causing symptoms and is associated with, though not proven to cause, preterm birth. Untreated trichomoniasis carries stronger links to preterm delivery and low birth weight, which is why CDC recommends treating it. Group B strep carriage is addressed during labor rather than earlier.

Do I need a follow-up test after treatment for a vaginal infection in pregnancy?

For trichomoniasis, CDC recommends retesting within three months because reinfection is common. For BV, recurrence is frequent and some guidance suggests a repeat evaluation during pregnancy may be considered, especially if symptoms persist. For yeast, a recheck is usually reserved for symptoms that do not settle or return. Your care team decides which applies based on your history and response.

Can a vaginal infection during pregnancy affect delivery?

Group B strep has the clearest effect: a positive swab between 36 and 37 weeks leads to antibiotics through a vein during labor to lower transmission to the baby. Active yeast at delivery can pass to the newborn as oral thrush or diaper rash, both treatable. Trichomoniasis is associated with early delivery, which is why it is treated when found. Your birthing team plans around any confirmed result.

References

• CDC – Bacterial Vaginosis: STI Treatment Guidelines
• CDC – Vulvovaginal Candidiasis: STI Treatment Guidelines
• CDC – Trichomoniasis: STI Treatment Guidelines
• CDC – About Group B Strep

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.